Your browser doesn't support javascript.
loading
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Rinnerthaler, Gabriel; Gampenrieder, Simon Peter; Petzer, Andreas; Burgstaller, Sonja; Fuchs, David; Rossmann, Dieter; Balic, Marija; Egle, Daniel; Rumpold, Holger; Singer, Christian F; Bartsch, Rupert; Petru, Edgar; Melchardt, Thomas; Ulmer, Hanno; Mlineritsch, Brigitte; Greil, Richard.
Afiliação
  • Rinnerthaler G; IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
  • Gampenrieder SP; Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.
  • Petzer A; Cancer Cluster Salzburg, Salzburg, Austria.
  • Burgstaller S; IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.
  • Fuchs D; Salzburg Cancer Research Institute with Laboratory of Immunological and Molecular Cancer Research and Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.
  • Rossmann D; Cancer Cluster Salzburg, Salzburg, Austria.
  • Balic M; Internal Department I for Medical Oncology and Hematology, Ordensklinikum Linz Barmherzige Schwestern, Linz, Austria.
  • Egle D; IVth Department of Internal Medicine with Hematology and Medical Oncolocy, Klinikum Wels-Grieskirchen, Wels, Austria.
  • Rumpold H; Department of Internal Medicine 3 - Hematology and Oncology, Kepler University Hospital, Linz, Austria.
  • Singer CF; 2nd Medical Department, County Hospital Steyr, Steyr, Austria.
  • Bartsch R; Division of Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
  • Petru E; Department of Obstetrics and Gynaecology, Innsbruck Medical University, Innsbruck, Austria.
  • Melchardt T; Department of Oncology, Hematology and Gastroenterology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria.
  • Ulmer H; Department of Obstetrics and Gynecology, Cancer Comprehensive Center, Medical University of Vienna, Vienna, Austria.
  • Mlineritsch B; Department of Internal Medicine 1, Division of Oncology, Cancer Comprehensive Center, Medical University of Vienna, Vienna, Austria.
  • Greil R; Department of Obstetrics and Gynaecology, Clinical Department of Gynecology, Medical University Graz, Graz, Austria.
BMC Cancer ; 18(1): 1074, 2018 Nov 06.
Article em En | MEDLINE | ID: mdl-30400780
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Neoplasias de Mama Triplo Negativas / Glicina Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Boro / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatina / Neoplasias de Mama Triplo Negativas / Glicina Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Áustria